Moebius Jeannette M, Widera Darius, Schmitz Juergen, Kaltschmidt Christian, Piechaczek Christoph
Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
BMC Immunol. 2007 Aug 6;8:13. doi: 10.1186/1471-2172-8-13.
Siglec-7, a sialic acid binding inhibitory receptor expressed by NK cells is masked in vivo by a so far unknown ligand. It shows a strong binding prevalence for alpha-2,8-linked disialic acids in vitro.
Here we describe the expression of PSA-NCAM (alpha-2,8-linked polysialic acid modified NCAM) on functional adult peripheral blood natural killer cells and examine its possible role in masking Siglec-7. Unmasking of Siglec-7 using Clostridium perfringens neuraminidase massively reduces NK cell cytotoxicity. By contrast a specific removal of PSA using Endo-NF does not lead to a reduction of NK cell cytotoxicity.
The results presented here therefore indicate that PSA-NCAM is not involved in masking Siglec-7.
唾液酸结合免疫球蛋白样凝集素-7(Siglec-7)是一种由自然杀伤(NK)细胞表达的唾液酸结合抑制性受体,在体内被一种迄今未知的配体所掩盖。它在体外对α-2,8-连接的二唾液酸具有很强的结合优势。
在此我们描述了多唾液酸神经细胞黏附分子(PSA-NCAM,α-2,8-连接的多唾液酸修饰的神经细胞黏附分子)在功能性成人外周血自然杀伤细胞上的表达,并研究其在掩盖Siglec-7方面的可能作用。使用产气荚膜梭菌神经氨酸酶解开Siglec-7会大幅降低NK细胞的细胞毒性。相比之下,使用内切神经氨酸酶NF特异性去除PSA并不会导致NK细胞细胞毒性降低。
因此,此处给出的结果表明PSA-NCAM不参与掩盖Siglec-7。